230 related articles for article (PubMed ID: 17627828)
1. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs.
López GV; Batthyány C; Blanco F; Botti H; Trostchansky A; Migliaro E; Radi R; González M; Cerecetto H; Rubbo H
Bioorg Med Chem; 2005 Oct; 13(20):5787-96. PubMed ID: 15993614
[TBL] [Abstract][Full Text] [Related]
3. NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties.
Boschi D; Tron GC; Lazzarato L; Chegaev K; Cena C; Di Stilo A; Giorgis M; Bertinaria M; Fruttero R; Gasco A
J Med Chem; 2006 May; 49(10):2886-97. PubMed ID: 16686532
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
5. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
6. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
[TBL] [Abstract][Full Text] [Related]
7. NO-donor melatonin derivatives: synthesis and in vitro pharmacological characterization.
Chegaev K; Lazzarato L; Rolando B; Marini E; Tosco P; Cena C; Fruttero R; Bertolini F; Reist M; Carrupt PA; Lucini V; Fraschini F; Gasco A
J Pineal Res; 2007 Apr; 42(4):371-85. PubMed ID: 17439554
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
9. Effects of nitric oxide donor antioxidants containing the phenol vitamin E substructure and a furoxan moiety on ischemia/reperfusion injury.
Di Stilo A; Chegaev K; Lazzarato L; Fruttero R; Gasco A; Rastaldo R; Cappello S
Arzneimittelforschung; 2009; 59(3):111-6. PubMed ID: 19402340
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric synthesis and biological activity of nor-α-tocopherol, a new vitamin E analogue.
Chapelat J; Hengartner U; Chougnet A; Liu K; Huebbe P; Rimbach G; Woggon WD
Chembiochem; 2011 Jan; 12(1):118-24. PubMed ID: 21161968
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of furoxancarbonitriles as a new class of vasodilators.
Gasco AM; Boschi D; Di Stilo A; Medana C; Gasco A; Martorana PA; Schönafinger K
Arzneimittelforschung; 1998 Mar; 48(3):212-8. PubMed ID: 9553676
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and vascular relaxing activity of arecoline derivatives coupled with nitric oxide donors].
Huang ST; Huang WL; Zhang HB
Yao Xue Xue Bao; 2006 Jan; 41(1):71-5. PubMed ID: 16683531
[TBL] [Abstract][Full Text] [Related]
13. New potential uroselective NO-donor alpha1-antagonists.
Boschi D; Tron GC; Di Stilo A; Fruttero R; Gasco A; Poggesi E; Motta G; Leonardi A
J Med Chem; 2003 Aug; 46(17):3762-5. PubMed ID: 12904082
[TBL] [Abstract][Full Text] [Related]
14. Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties.
Cena C; Chegaev K; Balbo S; Lazzarato L; Rolando B; Giorgis M; Marini E; Fruttero R; Gasco A
Bioorg Med Chem; 2008 May; 16(9):5199-206. PubMed ID: 18359636
[TBL] [Abstract][Full Text] [Related]
15. Water soluble furoxan derivatives as NO prodrugs.
Sorba G; Medana C; Fruttero R; Cena C; Di Stilo A; Galli U; Gasco A
J Med Chem; 1997 Feb; 40(4):463-9. PubMed ID: 9046336
[TBL] [Abstract][Full Text] [Related]
16. Edaravone derivatives containing NO-donor functions.
Chegaev K; Cena C; Giorgis M; Rolando B; Tosco P; Bertinaria M; Fruttero R; Carrupt PA; Gasco A
J Med Chem; 2009 Jan; 52(2):574-8. PubMed ID: 19113954
[TBL] [Abstract][Full Text] [Related]
17. Nitrosyl-cobinamide, a new and direct nitric oxide releasing drug effective in vivo.
Broderick KE; Alvarez L; Balasubramanian M; Belke DD; Makino A; Chan A; Woods VL; Dillmann WH; Sharma VS; Pilz RB; Bigby TD; Boss GR
Exp Biol Med (Maywood); 2007 Dec; 232(11):1432-40. PubMed ID: 18040067
[TBL] [Abstract][Full Text] [Related]
18. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties.
Chegaev K; Lazzarato L; Tosco P; Cena C; Marini E; Rolando B; Carrupt PA; Fruttero R; Gasco A
J Med Chem; 2007 Apr; 50(7):1449-57. PubMed ID: 17335184
[TBL] [Abstract][Full Text] [Related]
19. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
20. Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid.
Lazzarato L; Donnola M; Rolando B; Marini E; Cena C; Coruzzi G; Guaita E; Morini G; Fruttero R; Gasco A; Biondi S; Ongini E
J Med Chem; 2008 Mar; 51(6):1894-903. PubMed ID: 18293898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
